Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (10)

2023

  1. Descending mediastinitis that simulates a pharyngo-laryngeal neoplasm

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 193-194

  2. Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 8, pp. 2486-2500

2021

  1. Dependency of the remnant 131I-NaI biokinetics on the administered activity in patients with differentiated thyroid cancer

    Physica Medica, Vol. 88, pp. 45-52

2018

  1. BRAF V600E mutation in papillary thyroid cancer and its effect on postoperative radioiodine (131I) therapy: Should we modify our therapeutic strategy?

    Cirugia Espanola, Vol. 96, Núm. 5, pp. 276-282

  2. Detection and quantification of 223Ra uptake in bone metastases of patients with castration resistant prostate carcinoma, with the aim of determining the absorbed dose in the metastases

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 1, pp. 20-27

2016

  1. PET/CT imaging with 18F-FDG in Castleman disease

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 35, Núm. 3, pp. 200-201

  2. Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer

    Medical Physics, Vol. 43, Núm. 10, pp. 5279-5287

2013

  1. Pseudoaneurisma arterial como falso positivo de infección en la gammagrafía ósea y con leucocitos marcados en un paciente con prótesis total de cadera

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 5, pp. 334-335

2008

  1. Evidences in Nuclear Medicine. Selection of publications, July-December 2007

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 3, pp. 207-216

  2. Evidences in Nuclear Medicine. Selection of scientific articles, January-June 2008

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 6, pp. 445-459